Which of the following acts at site A?
Ans. B. VorapaxarVorapaxar does not affect ADP-mediated platelet aggregation, coagulation parameters, or bleeding time.A. Protease-activated receptor-1 (PAR-1) antagonists-VorapaxarB. Adenosine diphosphate (ADP) receptor inhibitors - Ticlopidine, Clopidogrel, Prasugrel, TicagrelorC. Glycoprotein IIB/IIIA inhibitors -Abciximab, Eptifibatide, TirofibanD. Irreversible cyclooxygenase inhibitors- AspirinE. OthersPhosphodiesterase (PDE3) inhibitor -CilostazolAdenosine reuptake inhibitor - Dipyridamole
Aspirin
Vorapaxar
Abciximab
Ticagrelor
Hematology